Calorie Intake Reduced When Menu Labels Display Amount Of Exercise Needed To Burn Calories

#bipolardisorder #zen

Nutrition / Diet News From Medical News Today
Calorie Intake Reduced When Menu Labels Display Amount Of Exercise Needed To Burn Calories
More restaurants are displaying calorie information on their menus than ever before. It’s not a coincidence; by law, retail food establishments that are part of a chain with twenty or more locations nationwide must disclose the calorie content of each menu item. The goal is to encourage consumers to make healthier, informed food choices…

Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg

Kicking a Food Addiction: Six Points On the Path to Peace

#bipolardisorder #zen

MedWorm: Binge Eating Disorder
Kicking a Food Addiction: Six Points On the Path to Peace
By now the scientific verdict is clear: some foods can spark cravings that rival those of any abused drug. These days, understanding and supports have solidified for the binger, though, and clearer paths to freedom can emerge. These paths often include six predictable points along the way.
read more (Source: Psychology Today Addiction Center)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg

FDA staff to ask expert panel if new trial needed for Aveo drug

#bipolardisorder #zen

Health News Headlines – Yahoo! News
FDA staff to ask expert panel if new trial needed for Aveo drug

A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver SpringBy Toni Clarke (Reuters) – Staff reviewers for the Food and Drug Administration will ask a panel of outside medical experts if another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc and Astellas Pharma Inc can be approved. In documents posted on Tuesday on the FDA's website, the reviewers said that in a late-stage trial, patients taking the drug, tivozanib, did not live longer than those who took a rival product. They asked whether a new trial was needed to better assess risk versus benefit, given that other treatments are available. …

Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg